Família AFIAS Adalimumab

Adalimumab (ADL) · class II · Valid

Registration no.
10350840428
Process no.
25351406589202211
Status
Valid
Device type
Adalimumab (ADL) (ADALIMUMAB (ADL))
Risk class
II
Registration holder
BIOSYS LTDA CNPJ 02.220.795/0001-79 · 506 registrations
Manufacturer
BODITECH MED INC. · South Korea
Published
27/10/2022
Valid until
No expiry (VIGENTE)
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other adalimumab (adl) registrations (4 in total, see all)

ProductClass HolderPublishedStatus
IDKmonitor® Adalimumab drug level ELISA
80464810758
II ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA 04/02/2021 Valid
BÜHLMANN Quantum Blue® Adalimumab
80102512062
II VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA 25/06/2018 Valid
PROMONITOR-ADL
80134860240
II GRIFOLS BRASIL LTDA 03/07/2017 Valid